Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research
Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research